Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 5 OTHER 4 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Refractory Differentiated Thyroid Gland Carcinoma 1 Pancreatic Neoplasms 1 Melanoma 1 Glioma 1 Brain Neoplasms 1

Interventions

Gemcitabine 17 Fluorouracil 8 Capecitabine 6 Radiotherapy 5 Leucovorin 5 Albumin-Bound Paclitaxel 5 Taxes 4 Irinotecan 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Specimen Handling 3 Radiotherapy, Conformal 3 Docetaxel 3 irinotecan sucrosofate 2 dehydroftorafur 2 Surgical Procedures, Operative 2 Radiosurgery 2 Pancreaticoduodenectomy 2 Chemotherapy, Adjuvant 2 Cetuximab 2 trametinib 1 tipifarnib 1 saracatinib 1 pegfilgrastim 1 lanreotide 1 ganitumab 1 durvalumab 1 conatumumab 1 beta-D-glucosylisophosphoramide mustard 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Pancreatic Neoplasms × trametinib × Clear all

NCT05518110 2026-04-13

PaTcH

Cancer Trials Ireland

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡